<DOC>
	<DOCNO>NCT01781702</DOCNO>
	<brief_summary>A Randomized , Double-blind , Multicenter , Phase 3 Study Pelubiprofen Tab . &amp; Celebrex Cap . Comparative Evaluation Safety &amp; Efficacy Rheumatoid Arthritis Patients</brief_summary>
	<brief_title>Phase 3 Study Pelubiprofen Tab . &amp; Celebrex Cap . Rheumatoid Arthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>1 . Adult males/Females age 18~80 year 2 . Patient take NSAIDs treatment rheumatoid arthritis 3 . Patients belong ACR functional class 1 , 2 , 3 1 . Patients belong ACR functional class 4 2 . Patients hypersensitive clinical trial medicine excipient 3 . Patients experience Cerebrovascular bleeding , bleed disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>